PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-human IgD, 100 tests
PE/Dazzle™ 594 anti-human IgD, 25 tests
PE/Dazzle™ 594 anti-human IgM, 100 tests
PE/Dazzle™ 594 anti-human IgM, 25 tests
PE/Dazzle™ 594 anti-human Ki-67, 100 tests
PE/Dazzle™ 594 anti-human Ki-67, 25 tests
PE/Dazzle™ 594 anti-human KLRG1 (MAFA), 100 tests
PE/Dazzle™ 594 anti-human KLRG1 (MAFA), 25 tests
PE/Dazzle™ 594 anti-human Siglec-8, 100 tests
PE/Dazzle™ 594 anti-human Siglec-8, 25 tests
PE/Dazzle™ 594 anti-human SSEA-4, 100 tests
PE/Dazzle™ 594 anti-human SSEA-4, 25 tests
PE/Dazzle™ 594 anti-human TCR Vα24-Jα18 (iNKT cell), 100 tests
PE/Dazzle™ 594 anti-human TCR Vα24-Jα18 (iNKT cell), 25 tests
PE/Dazzle™ 594 anti-human TCR Vα7.2, 100 tests